Implications on the introduction of transgenics in Brazilian maize breeding programs. by PARENTONI, S. N. et al.
Implications on the introduction of transgenics in Brazilian maize breeding programs
9Crop Breeding and Applied Biotechnology 13: 9-22, 2013
Implications on the introduction of transgenics in Brazilian maize 
breeding programs
Sidney Netto Parentoni1*, Rubens Augusto de Miranda1 and João Carlos Garcia1
Received 15 September 2012
Accepted 20 December 2012
Abstract – Transgenic maize was approved in Brazil in 2008/2009. In 2012, it occupied 73% of the country maize growing area. This 
high adoption rate confirms studies indicating that technology use has been the major driving force in Brazilian agriculture. Maize 
seed market in the world has been a concentrated sector. Although, when this sector is associated with transgenesis, this concentration 
increases sharply. In one side, there is the idea that companies can benefit from gains of scale and complementarities to maximize 
their efficiency in research and development (R&D). On the other side, this concentration may allow the exercise of “market power” 
by dominant companies. The objective of this study is to analyze the impacts of the adoption of transgenic technology in the arrange-
ments of maize breeding programs and seed production sector in Brazil. A critical analysis of the situation of the breeding programs 
that do not have this technology is made.
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INTRODUCTION
Biotechnology and transgenesis have shown great value as 
complementary technological tools for cultivar development, 
which can add to these cultivars specific characteristics that 
would be difficult to obtain using conventional breeding. In 
the specific case of maize, the genetic modifications known 
as “first generation” have focused on insect resistance and 
herbicide tolerance traits. In July 2012, thirty-four transgenic 
products of maize, cotton and soybeans were commercially 
approved by the Brazilian Biosafety Technical Commission 
(CTNBio); eighteen of them are transgenic maize.
In different situations, questions have been raised re-
lated to the possible negative impacts of transgenic crops 
to human health or to environmental risks. However, to 
date, there is no scientific evidence of these risks in the 
genetic modified technology released for commercial use 
in the country. Instead, its high rate of adoption in Brazil 
indicates that this technology has contributed to the solution 
of some important demands of the farmers: technologies 
that reduce risk (e.g., control of fall armyworm using Bt 
technology) and an increase in operational convenience 
(e.g. larger and easier to do herbicide spraying period, as 
in RR technology). However, the changes that the adoption 
of these technologies have brought to the arrangement of 
breeding programs to the companies that can´t directly have 
access to these technologies and the consequences in the 
medium and long term that this technology may bring to 
the country have been slightly analyzed under a national 
strategic vision.
Allogamous seed market worldwide generally shows 
a higher level of concentration than what is observed in 
autogamous crops. The reason is that the exploration of 
heterosis using hybrids as well as intellectual property 
guaranteed by the ownership of parental inbred lines have 
allowed the private sector, in allogamous crops, to be more 
efficient in obtaining financial support oriented for breed-
ing programs. This has resulted in increased investments 
for innovation in genetics and biotechnology in this sector. 
The high investment required to develop a new transgenic 
product from the research phase to its worldwide deregula-
tion in import markets (required in the case of commodities) 
led to a concentration of the world market for maize seeds 
in this last decade much higher than what was observed 
at the beginning of the 90s (Howard 2009). The cost for 
developing transgenic innovations has greatly reduced the 
number of companies with sufficient availability of resources 
to participate in this activity. This has constituted as a bar-
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rier to the use of this technology by other companies. This 
barrier is much larger than that represented by the costs of 
conventional breeding programs. Besides the technological 
innovation in seed component, the large chemical corpora-
tions that now dominate this market have included extensive 
marketing programs coupled with an aggressive commercial 
verticalization policy (simultaneous sale of agricultural inputs 
such as seeds and pesticides, technical assistance and, oc-
casionally, crop financing and purchase of grain production). 
This model is now consolidated in the United States, where 
public maize breeding programs (mainly at the Universities) 
and independent programs on small and medium companies, 
which do not have technological alliance with the trait hold-
ers, have almost disappeared. The concentration in seed and 
biotechnology sector can be seen by looking at the market 
share of the eight largest firms which was 29% in 1994 and 
raised to 63.4% in 2009 (Fuglie et al. 2012b).
The phenomenon of globalization and concentration 
of companies have proved to be universal in areas like 
telecommunications, information technology, production 
of cell phones, automotive industry, banking and others. An 
interesting point is that most of the products and services 
offered by these segments can be developed and manufac-
tured anywhere in the world and are easily transferred to the 
market where it will be sold. In agriculture, considerations 
relating to food biosafety and environmental impacts require 
greater local action of companies, so that legal require-
ments of each country are observed. This implies in a high 
operational cost, which can only be funded by companies 
with large financial and organizational capability. In the case 
of the Brazilian economy, which is still strongly based on 
agriculture, the development of new cultivars, their seed 
production and efficiency tests of events against pests and 
weeds, for example, must be conducted locally. Brazil is 
a country of continental proportions, with a diversity of 
soils and environments that range from subtropical areas 
to latitudes close to the Equator. The savannah area (known 
as Cerrado), for instance, presents great variation in rainfall 
and a mosaic of altitudes, ranging from sea level to above a 
thousand meters plateaus. Moreover, there are at least two 
cropping seasons in the country (first and second crops), 
with different soil conditions, temperature and rainfall. This 
variety of environments, and consequently the biotic and 
abiotic stresses that affect crops in the country, is bigger than 
those present in the United States Corn Belt, for example. 
This becomes a challenge for breeding programs in Brazil, 
especially when considering broad adaptation strategies 
versus specific adaptation strategies in cultivar selection.
As part of these large biodiversity in Brazil compared to 
other temperate countries, it should be expected that more 
problems would be faced by the transgenic technology in 
tropical conditions with two cropping seasons per year. In 
fact, in the 2012/2013 summer season in Brazil, a number 
of reports from farmers and agronomists have indicated 
the occurrence of fall armyworm (Spodoptera frugiperda) 
attacks higher than it would be expected in some fields with 
transgenic Bt maize. At this moment, there is no explanation 
if more extreme weather conditions or other factors should 
be influencing this situation. The new stacked events with 
two or more Bt genes have shown higher levels of resistance 
than some single gene events in the conditions described 
above, but it should be expected that the gene stacking op-
tion alone also would not be a unique durable solution for 
the insect control problem. At the beginning, Bt technology 
was seen by farmers as a single solution to solve all their 
problems related to target insects. Farmers in Brazil stopped 
doing “Integrated Pest Management System” (IPM) and in 
some cases also abandoned other recommended practices 
such as the planting of refuge areas with conventional 
materials. It is becoming clear that transgenics for insect 
control is one important tool that should be used as part of 
an IPM and not as a single strategy. In this regard, private 
x public partnerships would be valuable tools to develop 
and implement IPM systems.
As mentioned above, seed market concentration has a 
number of different implications to be considered. In the case 
of maize seed industry, one point to be analyzed is related 
to the logistics of seed distribution in different regions of 
a large country such as Brazil and also for the two annual 
cropping seasons. This means that in a situation of a highly 
concentrated seed market, with few companies, a frustration 
in seed production in one of these large companies, or even 
an unexpected change in seed demand, could reduce access 
to seed input, and unpredictably affect maize production in 
the country, which is the basis of all national chain of meat 
and dairy products.
Thus, the existence of a larger number of breeding pro-
grams and maize seed industries seem to be good for the 
national economy by increasing the variability of cultivated 
germplasm in the country (which reduces vulnerability to 
biotic risks, like new pests and diseases), increasing seed 
distribution channels (local firms may specialize in meeting 
the demands of a particular geographic area, and of certain 
technological segments that complement the performance 
of larger companies) and improving the buffering capacity 
and regulation of seed prices in these markets.
GENERAL INFORMATION ON MAIZE 
SEED MARKET CONCENTRATION AND 
BRAZILIAN AGRICULTURE
In order to explore the potential synergy between differ-
ent areas, in the 1990s and early 2000s, a series of mergers 
and acquisitions among pharmaceutical, agrochemical and 
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seed industries was observed worldwide (Fernandez-Cornejo 
2004, Howard 2009).
In Brazil, the wave of mergers and acquisitions that 
restructured the international seed market began in the late 
1990s. At that time, Brazil had about twenty-two companies 
with their own maize breeding programs in the country, 
including nineteen private companies (five of which were 
multinationals), and three public companies (Embrapa, 
CATI and IAC). Embrapa (Brazilian Agriculture Research 
Company) had formed a group of about 28 licensed com-
panies (called “Unimilho”). Altogether, approximately fifty 
companies were selling maize seeds in the country in the 
1990s (Antonialli 2012).
The acquisition of seed companies in the country by 
large international groups (mainly from the pharmaceutical 
and agrochemical areas) was a strategy that these groups 
found to obtain new assets (germplasm and structures of 
production, distribution and marketing of seeds available 
in the country) which would complement and add value to 
the assets they already possessed, like biotechnology and 
capital (Guerrante 2011). The acquisitions that occurred in 
2011 and 2012 indicate that this process is still ongoing. 
Table 1 presents the major acquisitions in the sector, which 
has restructured the Brazilian maize seed market.
However, one must consider that the business of maize 
seeds in the country had already presented a tradition of 
concentration over the 80s and the 90s. As an example, dur-
ing that time, the company Agroceres (Brazilian company 
which was acquired by Monsanto in 1999) held close to 
40% of the country maize seed market share. In the new 
scenario, the concentrated market structure remained, but 
the seed market started to be almost completely controlled 
by chemical companies.
The effects of the concentration in the seed market still 
lack studies, but in theory they could result in two different 
situations. On the one hand, there is the idea that the seed 
companies can benefit from gains of scale and complemen-
tarities to increase the efficiency of their R&D. On the other 
hand, there is the possibility that the concentration allows 
the use of market power by dominant companies. This lat-
ter situation may result in reduced rates of innovation in the 
sector and/or higher seed prices. The first analysis of these 
conflicting aspects in biotechnology between concentration 
and increased ability of innovating (known as “competition and 
efficiency”) versus aspects of total market control (known as 
“equity”) was made in a pioneering work by Elzinga (1977). 
This author analyzed that a balance between competition and 
concentration (regulated by the market) and the antitrust laws 
(regulated by the State) should occur in order to ensure both 
the innovative power of companies and the society’s interests.
Schimmelpfenning et al. (2004) investigated the impacts 
of changes in the market of maize, cotton and soybeans in the 
United States, and found evidence of an inverse relationship 
between the concentration and amount of research. Silva et 
al. (2012) conducted a similar study in Brazil, covering the 
same markets. Among the findings of these last authors, it is 
noteworthy that, despite the centralizing trend in the analyzed 
period (1999 to 2010), there is no evidence of exercise of 
market power on prices, productivity of innovations and 
change in the number of registers in the National Cultivar 
Registration System - RNC. In relation to maize, the results 
of Silva et al. (2012) should be analyzed as a preliminary 
view, since the advent of transgenic seeds was still incipient 
at the time of the study (only two years of commercialization), 
and marketing such technology is clearly a structural break.
Fuglie et al. (2012b) analyzed the effects of concentra-
tion in industry agriculture inputs. The authors mention that 
farm inputs have been rising faster than the prices farmers 
receive for their crops in the U.S. The largest increase over 
1990-2010 was in crop seed prices, which more than doubled 
relative to the price received for agricultural commodities.
Shin and Chavas (2010) and Shin et al. (2010b) found 
evidences that in the American market, the prices of soybean 
and cotton, respectively, tend to be higher in verticalized 
arrangements or in authorization for distribution than in 
those observed in the transfer of transgenic technology by 
licensing it. In the latter, the authors conclude that “this 
indicates that vertical integration achieved by biotechnology 
companies could increase the exercise of the market power 
and the ability of companies to obtain economic benefits 
from retail seed stores and farmers”.
Currently, the market for transgenic maize in the U.S. 
is dominated by seeds planted with 2-4 stacked events, 
but it is possible to find seeds stacked up to 8 events. This 
procedure does not blow up the prices of seeds by the fact 
that the pricing of each event occurs in a sub-additive way. 
In other words, the additional events incorporate a value 
less than proportional to the premium paid for a single 
Table 1. The most important mergers/acquisitions of maize seed company 
in Brazil
Acquiring Company Acquired Company
Monsanto Agroceres, Cargill, Braskalb and Agroeste
Dow Dinamilho, FT Biogenética, Híbridos Colo-rado, Hatã, Agromen
Nidera
Bayer-Sementes Brasil (formed from the 
acquisition of Ribeiral, Mogiana, Fartura and 
Mitla)
Limagrain Brasmilho (formed of Planagri, Semel, For-tuna and Semear) and Guerra-PR
KWS Riber, Delta and Semilla
Source: Own elaboration
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event in a seed (Shin et al. 2010a). More studies related to 
the impacts of market concentration of seeds in Brazil are 
required to support public policies in this area.
Despite the commercial production of genetic modi-
fied grains started in the mid-1990s in the United States, in 
Brazil the technology was first used in maize fields only in 
the 2008/09 crop and in small quantities. The maize crop of 
2011/12 is the third season in which the availability of geneti-
cally modified maize seed is relevant in terms of quantity and 
trait options for farmers. During this crop season, the use of 
genetic modified seeds, in total seed market, was 73% (sum-
mer 2011/12) versus 36% in the summer crop of 2009/10, 
indicating a wide domain of this technology in the commercial 
seed market. The Brazilian second cropping season called 
“safrinha” can be defined as a crop rotation is to first plant a 
crop of rain-fed such as soybean or rice, and then after these 
crops are harvested, plant a second crop of maize, sorghum, 
cotton or wheat. Safrinha can also be defined as a farming 
strategy whereby the farmer takes advantage of a long tropi-
cal growing season to produce two crops in a single growing 
season, thereby maximizing revenue per hectare. This new 
fact also causes concerns because genetic modified crops 
(GMO) are planted after GMO crops, and insects are always 
exposed to crops even during the dry season. In Brazilian 
second crop, the percentage of transgenic maize seed rose 
from 39% (in 2010) to 64% (in 2011), reaching 83% of the 
marketed seeds in 2012.
The situation above refers to the relative participation 
of transgenic events regarding the sale of seeds. In the sum-
mer crop, there is a reasonable percentage of less technified 
farmers, especially in the North and Northeast of Brazil, 
which use their own seeds (saved from previous crops), or 
open pollinated varieties seed distributed by governmental 
programs, and this covers more than 2 million hectares. In 
this sense, considering the total area planted with maize in 
the country (which includes crops planted with commercial 
seed and crops planted with seeds saved by farmers) the 
percentage of use of transgenic seeds decreases to 53.5% 
(2011/12 crop) during summer plantings.
RISKS ASSOCIATED WITH THE 
CONCENTRATION OF THE MAIZE SEED 
INDUSTRY IN BRAZIL
In the case of maize seed market in Brazil, there is a 
concern with the fact that the widespread use of transgenic 
technology may lead to an excessive concentration of this 
market. However, the market for maize seeds has a high 
degree of concentration due to the predominance of hybrid 
cultivars (whose development requires investment in research), 
and to the high expenses needed in programs of seed qual-
ity, post-sales and marketing activities. When considering 
only the transgenic seed market, the structure is even more 
concentrated. It can be observed in Table 2 that the events 
of genetic modified seeds of Monsanto, DuPont-Pioneer and 
Table 2. Sale of transgenic maize seed separated by type of event, from 2009/2010 to 2011/2012, in Brazil
Event
2009/10 second crop 2010/11 summer 2010/11 second crop 2011/12 summer
GMO
quantity
(in bags)
(%)
GMO
Quantity
(in bags)
(%)
GMO
quantity
(in bags)
(%)
GMO
quantity
(in bags)
(%)
NK 603 11.192 0.2 51.404  1.1
Total RR 11.192 0.2 51.404  1.1
BT 11 258.929  11.3 288.347  9.8 530.629 12.7 261.884  5.6
MIR 162 149.737  3.2
MON 810 1.520.444  66.4 961.238  32.9 1.379.475 33.1 712.776 15.4
MON 89034 240.383  8.2 420.101 10.1 913.473 19.8
TC 1507 510.461  22.3 1.429.573  48.9 1.726.840 41.5 2.234.111 48.4
Total Bt 2.289.834 100.0 2.919.541 100.0 4.057.045 97.5 4.271.981 92.5
BT 11 x GA 21 20.535 0.4
BT 11 x MIR 162 x GA 21 5.193 0.1
MON 810 x NK 603 92.779  2.2 59.443 1.2
MON 89034 x NK 603 128.452 2.7
TC 1507 x NK 603 77.016 1.6
Total stacked 92.779  2.2 290.639 6.3
General total 2.289.834 100.0 2.919.541 100.0 4.161.016 100.0 4.614.024 100.0
Source: Data from “Associação Paulista dos Produtores de Sementes e Mudas” (APPS)
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Dow have a market share over 90% related to the total maize 
seed with transgenic events in the Brazilian market.
Table 3 shows the availability of maize cultivars in the 
Brazilian market for the next crop and for the last seven 
crop seasons. There was a sharp increase in the number 
of cultivars that have been made available by companies 
in the early commercialization stages of genetic modified 
seeds. This was due to the fact that the new transgenic cul-
tivars were versions of pre-existing conventional cultivars 
which were made available with new traits. After the peak 
in 2010/2011 cropping season, when 497 cultivars were 
made available, this cultivar number has been dropping. It 
is noteworthy that, despite of the high number of cultivars 
registered in the country, in fact, an analysis of cultivars 
that would occupy 80% of the maize growing area in the 
country in a given year, will be a much smaller fraction than 
the numbers shown above. However, this evaluation must 
be done carefully, since there is not enough information to 
analyze accurately and reliably the possibility of a decrease 
in the speed of new products releases by breeding programs. 
It should be pointed out that the continuous release of new 
cultivars with higher yield potential and yield stability is 
what will ensure the growth of crop productivity in the 
country. So far, transgenic events have been used to promote 
crop protection (as in insect resistant traits), or to facilitate 
field operations (as seen in herbicide resistant traits) than 
to increase yield potential of the new cultivars.
Another parameter to be analyzed in the seed market 
concentration is the product price (in the case of maize seeds 
with transgenic technology). Dominant industries are inter-
ested in controlling the prices of their products. Although 
the amount of time since the introduction of this technology 
in Brazil is still short, there is evidence of a trend that the 
difference in price among genetic modified maize seeds and 
conventional seed is increasing. However, the most striking 
effect is found in the reduced prices for conventional seeds 
(which could be explained by the smaller market acceptance 
of conventional seeds, or by the concentration of this type 
of seeds towards products with lower market value, such as 
double cross hybrids or open pollinated varieties). In order 
to illustrate these arguments, it is observed in Figure 1 that, 
so far, there is a trend of increase in sales of transgenic seeds 
in higher price ranges. On the other hand, in the case of 
conventional seeds, there is a clear concentration movement 
of seed sales in smaller price ranges. To support this argu-
ment, it should be mentioned that 53.1% of conventional 
maize seeds sold in the summer of 2009/10 were priced to 
R$ 150.00 (US$ 75.00), while in the summer of 2011/12 
this percentage increased to 78.9% (Figure 1).
In relation to the types of events that have been used 
in maize in Brazil (until 2012 cropping season), there is a 
predominance of Bt transgenic single event cultivars, with 
fewer cultivars with stacked genes (either with different 
Bts or Bts+RR). The trend seems to be that the stacked 
events will increase their participation in the next cropping 
seasons, but at this moment it is not possible to anticipate if 
it will reach the American levels. In Brazil, the production 
systems are more complex than those used in the U.S., with 
two or more cropping seasons in a single year. In this case, 
RR events, for example, may present problems for weed 
management in maize as a second crop, when it would 
be planted RR maize after RR soybean. This could greatly 
reduce the time to develop resistance to this herbicide by 
increasing selection pressure for weed resistance. Another 
problem that has already been observed in many farms, 
mainly in Paraná State in Brazil, is that the remnants of a 
maize crop (ears lost during the crop harvest which stays 
in the field) can become a problem for the next soybean 
crop in the RR weed control system. One point that was 
not raised before is that, even if a farmer wants to cultivate 
only Bt maize (or not to use Bt plus RR maize previous to 
its soybean RR crop), the maize field could be pollinated by 
a neighbor’s RR field, and the remnants ears will have the 
RR trait. In the 2012 cropping season, a number of farmers 
had to mechanically control maize plants from the previous 
crop in the soybean RR fields, because these maize plants 
competed with soybean plants and also caused problems 
in the harvest machines.
Facts like those described above would indicate that in 
the areas where a second crop is cultivated in the same year 
in Brazil (generally soybean in the summer and maize in the 
winter), farmers will be interested in acquiring seeds only 
with Bt trait (without RR). Although, due to the effort to 
convert conventional inbred lines into transgenic ones for 
different events, the company’s strategy has been to simul-
taneously use a number of different events in a single inbred 
line. This would be a first example of possible conflict of 
interest between the companies that provide the technology, 
Table 3. Availability of maize cultivars in the Brazilian market, from 2005/06 to 2012/2013
Type of cultivar 2005/06 2006/07 2007/08 2008/09 2009/10 2010/11 2011/12 2012/13
Conventional cultivars 237 279 278 302 325 361 316 263
Trangenic cultivars 0 0 0 19 104 136 173 216
Total cultivars 237 279 278 321 429 497 489 479
Source: Embrapa Milho e Sorgo
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which are prepared to sell both traits-Bt and RR together in 
the same cultivar, and the interest of the farmer, who wants 
to buy only Bt trait. It would be relevant to follow what will 
happen in the future related to this issue.
With the release of transgenic maize in Brazil, in 2012, 
only four companies had their own transgenic maize prod-
ucts (Monsanto, Dow, Syngenta and DuPont-Pioneer). 
Monsanto and Dow have adopted the policy of giving to 
some companies the right of using the traits contained in 
their proprietary lines. Syngenta and DuPont-Pioneer have 
prioritized the use of transgenesis only in their own breeding 
programs. So far in Brazil, the policy of allowing companies 
which have their own maize breeding programs, to use traits 
licensed from third parties in its own germplasm, has been 
almost nonexistent. This indicates that the model which will 
probably be adopted in Brazil is to pass through contracts/
agreements, both genetics and traits, creating a network of 
distributors with different trademarks for the genetics and 
biotechnology of a small number of companies, which hold 
the technology. The natural consequence of the predominance 
of the genetics of fewer companies may be a reduction in the 
genetic base of maize grown in the country, with the risks 
that it implies, mainly linked to susceptibility of a certain 
germplasm to specific biotic stresses. The fact of narrowing 
of the genetic base x plant disease susceptibility, has oc-
curred in different historical periods, and was related to an 
epidemic caused by the fungus Helminthosporiun Turcicun 
race T. In the 70s, the vast majority of the maize grown in 
the U.S. and some of the hybrids produced in Brazil were 
generated using a system of cytoplasmic male sterility based 
on cytoplasm T. This germplasm showed high sensitivity to 
Helminthosporiun race T, which, at that time, caused losses 
of nearly 20% in the U.S. maize production. In Brazil, the 
relationship between susceptibility to some disease and maize 
germplasm of a given company was observed in the 90s, 
when the fungus that causes the disease known as grey leaf 
spot reached the country. During that time, the hybrids of 
a specific company proved to be much more susceptible to 
this disease than those ones from other companies, proving 
the relationship between narrower genetic basis of a single 
company and susceptibility to a particular disease. These 
examples showed that the standardization of the germplasm 
cultivated in the country, through market dominance by a 
few companies, may increase the risk of maize production, 
related to losses caused by new diseases and pests.
Another risk related to market concentration concerns the 
frustration of seed production that may occur in a leading 
company or a change in demand for seeds in view of situa-
tions that indicate increased demand for maize (e.g. drought 
in Argentina and in the USA in 2012 and expectation of 
Figure 1. Sales of transgenic and conventional maize seeds, separated by price range (R$), from 2009/2010 to 2011/2012, in Brazil. Source: Associação 
Paulista dos Produtores de Sementes e Mudas (APPS).
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higher profitability in the second crop in that year). In the 
early 2012, in the second cropping season, for the first time 
it was observed a difficulty for farmers in having access to 
seed input in the State of Mato Grosso at the desired time 
and location (Peres 2012). This may become more frequent 
with the trend of an increasingly concentrated market and 
without the buffering power of small seed companies.
THE ROLE OF PUBLIC SECTOR AS A 
SUPPLIER OF MAIZE GERMPLASM AND 
CULTIVARS IN THE COUNTRY: HISTORY 
AND NEED FOR PRIVATE-PUBLIC 
PARTNERSHIPS
The participation of the public sector as a national supplier 
of maize germplasm/cultivar in Brazil started in the 60s and 
70s, when there was an important participation of Universi-
ties and State Research Institutes, both in the introduction 
and selection of germplasm for the obtainment of cultivars 
that were marketed by private companies. Some examples 
were: the “Universidade Federal de Viçosa”, where the 
company “Agroceres” was originated; the “Escola Superior 
de Agricultura Luiz de Queiroz ESALQ-USP”, where, under 
the coordination of Professor Ernesto Paterniani, it was cre-
ated the  largest germplasm collection in the country at the 
time, and its breeding program produced open pollinated 
varieties such as Centralmex and Dentado Composto, which 
were widely used by farmers; the “Estação Experimental 
de Veranópolis” in the State of Rio Grande do Sul, where 
it was produced the double cross hybrids SAVE, which 
had high importance to southern agriculture in that period; 
and the “Instituto Agronômico de Campinas-IAC”, which 
produced the open pollinated varieties Azteca, Maya and 
the double cross hybrids from the Hmd series (e.g. Hmd 
7974), widely planted in the country, and which were used 
to initiate Cargill Seeds business in Brazil.
In 1973, the “Empresa Brasileira de Pesquisa Agro-
pecuária-Embrapa” was created by the Brazilian govern-
ment. Aiming to develop technological solutions for maize 
and sorghum in the country, the “Centro Nacional de Pes-
quisa de Milho e Sorgo” was created, and it was initiated 
a program in the areas of genetics and maize breeding. 
This program, at first, made  a large-scale introduction 
of improved germplasm in Brazil, derived mainly from 
CIMMYT-International Maize and Wheat Improvement 
Center, located in Mexico and also improved materials from 
other regions such as Suwan in Thailand. The introduced 
genotypes were crossed with materials adapted to Brazil 
(usually tall and of late maturity), and as a consequence of 
this process, about 50 new improved varieties were created 
and subjected to several cycles of recurrent selection to 
increase their adaptation to our ecosystems. These genetic 
materials were widely distributed. From 1980 to the 90s, 
about twelve thousand seed samples of these genotypes 
were distributed to public and private institutions in the 
country and abroad, and contributed to form the basis of 
the cultivated maize germplasm in the country.
In the late 70s and mid-80s, the State and the Universities 
breeding programs declined their participation as source of 
cultivar supply to small seed companies in the country. At 
that time the private sector of maize seed that had already 
been established in the country became increasingly modern 
and efficient, and started to invest more in their own breed-
ing programs. However, it began to emerge a new segment 
of small and medium companies that decided to invest in 
seed business and to seek partnership with Embrapa. This 
partnership was efficient in the 80s and 90s due to three 
main factors: a) the existence in Embrapa of an innovative 
breeding program that enabled the generation of hybrids 
and varieties with the following traits: short stature, high 
productivity, high seed producibility, which increased its 
economic attractiveness to private sector seed production, 
adapted to the various regions of the country, including areas 
of acid soils of the Brazilian Cerrado; b) the implementation 
of a sector of basic seed production at Embrapa which could, 
at that time, combined the production of large volumes of 
parental seeds with an efficient quality control of the seed 
business generated by these franchisees, and also provide 
technical and managerial assistance to a large number of 
small seed companies that were being established in the 
country; c) the implementation of an innovative model of 
public-private partnership with clear rules that gave legal and 
negotiating support to these new partnership arrangements.
This licensing model of public maize genetics to the 
private sector in the country began to show signs of ex-
haustion in the mid-90s due to the following factors: a) the 
competition among licensed companies, which produced the 
same cultivar; b) companies that had just started their own 
breeding programs wants to have exclusivity of products and 
use their own brand in cultivars name, which legally could 
not be implemented at that time due to public sector rules; 
c) the initiation of breeding programs in several companies, 
which started to seek technological partnerships to access 
inbred lines developed in the public sector, a model which 
the public sector has failed to implement in that moment; 
d) the vertical integration of cultivars generation processes 
started by large companies, involving commercialization, 
marketing, technical assistance, inputs supply and in some 
cases, purchase of production, reducing the market space 
for small and medium companies; e) the release of new 
maize cultivars with higher yield potential (initially three 
way crosses , and later, single cross hybrids) by private 
companies with their own breeding program (which gave 
support to the actions of item “d” above). For the farmer, 
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seed becomes one item in a complex package of supply 
inputs, services, credit, and commercialization guarantees.
Currently, Embrapa seeks for new models of public-
private partnerships in the areas of  genetic resources and 
maize cultivars. The focus is to meet the needs of different 
types of customers ranging from companies that do not have 
their own breeding program, small and medium companies 
with their own breeding programs, and even larger com-
panies, which can also transfer to the farmers the benefits 
achieved by public research. In this sense, new business 
models are being structured, such as: a) models that give 
exclusivity and allows the use of its own brand to private 
companies that want to have access to cultivars produced 
by the public sector, b) inbred lines licensing models as 
inputs to obtain jointly public-private hybrids c) “innova-
tion assets”, which can be: lines as sources of resistance to 
biotic or abiotic stresses; markers/Quantitative Trait Loci 
identified in sources of resistance to these stresses; genes/
knowledge associated with inheritance of these character-
istics; methods of screening and phenotyping for specific 
characteristics; populations (e.g. Recombinant Inbred Lines-
RILs, association panels, etc) for use in joint programs of 
genetics/physiology studies of specific characteristics. These 
advances will only be possible if the public sector will be 
able to operationalize it in an easy implementation structure 
of partnerships, within the legal framework to which public 
sector is subjected in the country.
The national public sector has sought to interact with 
the owners of traits in pursuit of contractual arrangements 
that allow the introgression of these traits in inbred lines 
developed by this sector. This action is in advanced stage 
in soybean and the expectation is that it also might become 
feasible in maize and cotton.
It should be emphasized the importance of private sector 
investment in R&D in the world and how it is important 
for the public sector to increasingly seek public-private 
partnerships. Fuglie et al. (2012a) report that, in 2010, the 
global private sector investment in R&D in agricultural 
inputs totalized US$ 11 billion, compared to U$ 5.6 billion 
in 1994. These authors also analyzed annual sales growth 
rates in 2006 in different sectors (animal feed, machinery, 
fertilizers, genetics and animal health, agrochemicals and 
biotechnology/seed). The highest annual growth rate in 
sales was seen in the fertilizer sector (8.3% annually), and 
biotechnology/seed (6.9% annually) obtained the second 
highest rate. The total amount of the plant chemical sector 
sales worldwide in 2010 was US$ 32 billion, with a growth 
rate of 1.8% per year. These numbers indicate that, keeping 
the annual growth rates observed in that study, by 2020, the 
market for biotechnology/seed in the world is expected to 
exceed the market value of agrochemicals.
It should be considered that with the growing concern 
related to environmental and health issues (climate change, 
environmental legislation after the Brazilian Forest Code 
approval, natural resources, etc) the national public sector 
in the breeding area will also have an important role in the 
search for solutions for medium/long-term problems such as 
higher production efficiency (efficient use of nutrients and 
water); minor impacts on the environment (use of national 
biodiversity for generating new biological products and its 
relationship with the genetics of the culture); reduced risks 
to the consumer (genetics and production technologies that 
reduce contamination, e.g., by mycotoxins); healthier foods 
(biofortification with vitamins and minerals). These advances 
will have significance only if there are efficient mechanisms 
for transferring them to the private sector (public-private 
partnerships) in order to make these solutions  available to 
farmers and consumers.
CHALLENGES AND OPPORTUNITIES FOR 
MAIZE BREEDING PROGRAMS IN THE 
COUNTRY IN THE POST-TRANSGENICS 
ERA
Brazil has been recognized as a major producer of maize, 
and in recent years it has become an important supplier to 
the international market. This has happened mostly due to 
technological adoption than through area expansion (Pereira 
et al. 2012). Brazilian farmers have proved to be avid for 
technological innovation to ease their operations and reduce 
their production risks. In this sense, the “first generation of 
transgenic” technology has had great acceptance by farmers 
and there are no signs that it will decrease.
Although the current scenario (2012) is a bit pessimistic 
about the future of breeding programs and of the medium 
and small maize seed companies in the country, outside 
the area of influence of the “biotechnological assets” (or 
“traits”) holders, the survival or not of this national seed 
sector (which is strategic for national agriculture) will be 
linked to a sequence of unpredictable events at the time and 
to the potential scenarios related to them. The analysis of 
some of these scenarios is made  below.
Policy of traits assignment to third parties
At least three different models of technology transfer 
in the biotechnological market of traits have been used 
(Stiegert et al. 2010). The first, known as “licensing model”, 
occurs when the holder is interested in getting a return on 
investment by receiving a technological fee for the use 
of the trait, regardless the genetics where it may be. The 
consequence is that, as more companies use the technol-
ogy, the greater is the economic return to the company 
who developed it, with smaller investments for setting 
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up a structure for seeds production and marketing. The 
licensing model “democratizes” the access to the technol-
ogy, and is the one with less impact on the concentration 
of the seed sector. The licensing model has been adopted 
by the holder of RR1 technology in soybeans in Brazil, 
which has been transferred to several companies in the 
country. This model maintains a competitive pressure on 
the market, keeping prices at lower levels. It also permits 
the survival of a number of breeding programs. As the 
number of available traits for licensing increases (ex. RR1, 
RR2 and Bt soybean), the issues related to stewardship of 
independent events also increase and as a consequence, 
only more organized companies would be able to follow 
the innovation pace of the market (the “license model” 
would become more restrictive regarding to the number 
of companies that would be eligible to use it).
A second alternative is the model of “authorization to 
commercialize”. In this model, the trait holder selects a 
number of companies to be the distributors. These com-
panies receive traits and genetics from the holder and get 
a percentage of sales, like a commercialization fee. Thus, 
there are two possibilities: first, companies directly receive 
hybrid seeds and do the processing and packaging with their 
own brand (it is necessary that the hybrid will be registered 
on the RNC with the brand of the company that will make 
the distribution). In other cases, the distributors have access 
to parental inbred lines, so they can cross them in order 
to produce hybrid in their own fields, pack and distribute 
the seeds with their brand. This distribution model causes 
a “false sense of diversity in the market”, where there are 
different brands, but the genetics belong to a small number 
of owners, who strictly control the price and quality.
A third form of technology transfer in the biotechnology 
market is the “vertical integration model”. Large compa-
nies which hold traits make agreements among them that 
lead to the stacking of events from different owners (the 
so called “cross license”) in order to obtain new combina-
tions of events, which are currently restricted to the group 
of the six major maize biotechnology companies. This 
would be a way of extending the shelf/commercial life of 
individual traits, recycling them into new combinations. 
This model also increases the economic return of a trait 
through its widespread use in different combinations and 
in a germplasm set that occupy large areas, but under the 
control of few companies (Wilson and Huso 2008). These 
agreements do not involve changing intellectual property of 
the individual components, but according to ETC (2008), 
it could be defined as a high concentration of technology.
Only in very few cases the owners of traits have given 
the right of use of these traits in genetics of third parties 
companies in Brazil. In this scenario, a new term arises, the 
so called stewardship, which means all the requirements made 
by the trait owners related to the quality of seed produced 
by a second company that will use this trait (including as-
pects of purity, vigor, biological expression of introgressed 
trait, control of production process with detailed records 
of all stages, tests for confirmation of purity of the event, 
etc.), combined with marketing aspects of the company 
that will receive the trait (including customer information, 
sales location and volumes, production characteristics, etc). 
The requirements related to these criteria has been held 
in such high standards that few companies in the country 
seem to have conditions to achieve them; thus, they are not 
considered qualified enough to use a certain trait. Another 
point is the contractual requirements made  by holders 
when assigning the right of use of traits, which generally 
have a quite complex structure and include a large number 
of items, two of which deserve special attention (Cañellas 
2012). The first is the right of holders to withdraw from the 
market certain trait any time they deems appropriate. In this 
case, all companies that have obtained the right to use the 
trait must also withdraw from the market all the products 
containing it. This situation reduces the commercial life time 
of a cultivar since the introgression of a trait and finalization 
of VCU tests take from four to five years (depending on the 
use or not of marker assisted selection), and the expected 
life of a trait on the market has been estimated around seven 
years. In many cases, the period of commercialization of a 
given hybrid with a licensed trait does not pay the costs of 
equivalency testing (conventional version x transgenic) and 
marketing of a hybrid. The second aspect relates to the next 
topic to be discussed in this paper, which is the expiration of 
certain patents related to certain trait or even the entry of it 
in the public domain. The right of use contract agreements, 
in general, contains clauses that prevent a company from 
using certain trait after it enters into the public domain. In 
this case, the company has to choose between signing a 
contract to have access to the technology in the present, 
and giving up a future right, which is to be able to have 
free access to the event after it falls into the public domain.
It is not certain the role that the public sector in the country 
is likely to have as an intermediary between the owners of 
traits and national companies, through the access to them in 
public genetics. The parties involved expect that a progress 
in these negotiations might be important for the country.
In 2009 the Department of Justice and the USDA held 
a series of workshops to examine the impacts of market 
concentration and the market power in different productive 
chains, including seeds and biotechnology. Some aspects of 
this work are discussed by Carstensen (2010). The author 
concludes that the concentration in this market has led to 
less technological competition and higher input prices.
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Entry of traits in the public domain after 
expiration of patents
An expectation of the national seed industry is the possibil-
ity of having access to biotechnology events when they come 
into the public domain after expiration of their patents. The 
pharmaceuticals are an example, having numerous products 
known as “generics” being produced in Brazil. However, there 
are several differences between the regulatory standards of the 
pharmaceutical sector and biotechnology events, which make 
this comparison difficult. The first big question is: when should 
the patent of a certain event expire? This question, although it 
seems simple, it is complex in nature for several reasons: a) 
there is no single patent, but a set of patents related to a given 
event; b) these patents are kept in different countries and this 
is done at different times, i.e., they will expire on different 
dates in different countries. A second question concerns the 
forms of deregulation of events in different countries, and if 
the product is targeted for domestic consumption (e.g., beans, 
cassava, etc) or if it is a commodity to be exported to several 
countries (e.g. soybean, maize, cotton, etc.). Biotechnology 
products with consumption only in Brazil follow the Brazil-
ian rules, dictated by the CTNBIO and aspects of supervi-
sion of the process are done by the Ministry of Agriculture 
(Mapa). CTNBIO defines issues related to biosafety of an 
event and is responsible for its authorization for test and use 
in the country. On the other hand, Mapa supervises the trials 
approved by CTNBIO, checks issues related to coexistence 
norms between GMOs and conventional materials and, as 
part of its activities, it is included the “Serviço Nacional 
de Proteção de Cultivares - SNPC” (National Plant Variety 
Protection), which standardizes the registration of variet-
ies (transgenic or conventional). A first difference between 
transgenic and pharmaceuticals products, is that in many 
regions of the world (USA and Europe for example), genetic 
modified materials are connected to at least three regulatory 
agencies (agriculture, environment and health), whereas 
pharmaceuticals are generally linked with the health agency. 
This makes the regulation of processes related to genetic 
modified organisms in the various countries much more 
complex than the one related to pharmaceuticals. In relation 
to products of domestic consumption, it must be verified that 
in the case of CTNBIO in Brazil, the approval for use of an 
event in the country is timeless, i.e., once it was approved, 
this authorization remains valid indefinitely, unless there is 
a detrimental effect identified on the event. In the case of the 
U.S. or E.U. countries, these regulatory agencies release the 
events for a specified period, after which the holder must 
provide documentation proving that it remains safe. In the 
case of the U.S., three agencies are involved in this process: 
the USDA - United State Department of Agriculture (which 
analyses issues related to agriculture), EPA - Environmental 
Protection Agency (which analyses environmental issues) and 
FDA - Food and Drug Administration (which analyzes health 
issues). If an event falls into the public domain, it is unclear 
whether the holder will continue to provide this documentation, 
and if this does not happen in the case of a commodity like 
maize, the trading companies probably will put restrictions on 
the purchase of products with these events (as they will have 
the same restrictions on exports to other markets). This will 
certainly have a negative effect on the price of grains from 
a cultivar containing this event, reducing its acceptance by 
farmers, and hence its use in breeding programs.
This fact (the possible non acceptance of an event in 
public domain by legal restrictions on market access) leads 
to a debate that has recently occurred in the U.S., and con-
cerns two possibilities for a breeding program: a) to keep 
the conventional breeding program and introgress events 
in the final stages of the development of inbred lines; b) 
to introgress the trait in the program basis. The latter, for 
example, occurred in soybean breeding program in several 
North American universities which, for a decade, crossed 
RR1 materials to obtain new lines with this event. With the 
possible expiration of the patent right for this event, and 
if the holder does not provide the documentation required 
by importing countries, all the breeding program of the last 
10 years of those universities would have to be discarded. 
An alternative would be the “cleaning or removal of the 
trait” from the germplasm, which would require time and 
resources. From this discussion, nowadays, all companies 
have chosen to keep their breeding programs using conven-
tional germplasm and to do the trait introgression at some 
point during the development of the materials.
Another fact to be considered is that, with the cross-
license, individual events are being used in stacked com-
binations with other events. Thus, it is expected that if an 
event is still safe (even after the expiration of its patent) in 
combination with other events, it should also be considered 
safe when supplied separately in a hybrid. This subject 
has been discussed in forums such as the Biotechnology 
Industry Organization (BIO) and the American Seed Trade 
Association (ASTA). Recently (USA 2012), these forums 
announced an agreement called “The Accord in Generic 
Event Marketability and Access Agreement (GEMAA), 
signed at this moment by five companies (BASF, Bayer, 
Dow, DuPont-Pioneer and Monsanto). This agreement 
was developed to address the transition of commercial 
biotechnology events as they go off patent. According to 
this document, the agriculture value chain would benefits 
from the GEMAA by setting out rights and obligations for 
signatories involved in commercializing biotechnology 
seed products containing off-patent biotechnology events 
to ensure that international regulatory and stewardship 
responsibilities would be maintained.
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Although there is some expectation about the possibil-
ity of using events after they fall into the public domain 
by breeding programs that do not had access to traits, so 
far there is no case in the world where this has actually 
happened. Moreover, the first events to fall into the public 
domain should be those with the lowest level of technological 
advancement, since they have been in the market for a long 
time, compared to events that have been recently released 
by the holders. A final remark in this issue is related to the 
fact that the use of a trait for breeding purpose is forbid-
den by all holders. This point indicates that the process of 
introgression of public domain trait should only be initi-
ated by a third part company, after it has fallen into public 
domain. This would delayed even more the possibility of 
commercially use this trait.
Maize traits generation by companies in the 
country
Brazil has been one of the countries that present a large 
investment in agricultural technology, with numerous univer-
sities and research centers with expertise in biotechnology. 
However, almost all basic researches in the development 
of traits have been made  abroad and mostly funded by the 
private sector. Some exceptions are the work that have been 
conducted by Embrapa and partners, which have already 
led to the approval by CTNBIO of two products for market-
ing in the country. The first one is a common bean cultivar 
resistant to golden mosaic virus (Aragão and Faria 2009). 
The second one, is the Cultivance soybean (Embrapa-BASF 
partnership), which is resistant to imidazolinone herbicides 
(Embrapa 2010). Two points should be considered when 
analyzing the development of transgenics in the country. The 
first is the technological challenge behind it and the need for 
complete knowledge of information related to intellectual 
property throughout the process. The second is related to 
the deregulation of the event in the target markets. In the 
case of a domestic consumption product, such as common 
beans, deregulation activities are conducted exclusively 
within the country, which facilitates the process. In the case 
of export commodities, such as soybeans and maize, which 
deregulation must be done according to the market it may 
be export to, the challenge of producing and deregulating 
an event goes far beyond the technological realm of trait 
generation process. The component of deregulation in global 
markets for which the product will be exported is still a 
huge challenge for the private sector, and even more for 
the public sector. This indicates that in the case of export-
able products, the most concrete possibility, in the medium 
term, of a national institution in developing a transgenic, is 
associating with a company that has global operations in the 
area of  deregulation. In this sense, the large international 
seed companies, for being derived mostly from the fields 
of pharmaceuticals and agrochemicals, already have all the 
know-how to fulfill the legal requirements for approval of 
new products into the various regulatory bodies of differ-
ent countries.
Opportunities for the development of non-
transgenic cultivars
Another possibility for national breeding programs that 
do not have access to traits would be to focus on the market 
of non-transgenic cultivars. It is now estimated that in the 
case of maize, this market makes up for about 20% of the 
marketed seed in the country. As for soybeans, there is an 
international demand for non-transgenic grains (where the 
importer is willing to pay a premium for this material), in 
the case of maize, this has not occurred yet. For this reason, 
in the case of maize, it has been difficult to create a system 
for prioritizing acquisition of non-transgenic grains. Another 
opportunity for programs of non-transgenic maize cultivars 
would be to act preferentially in the medium-low technol-
ogy market segment. Due to the operational difficulties in 
introgression, no major company has been working with 
double crosses transgenic hybrids. In this case, double cross 
hybrids or conventional open pollinated varieties, suitable 
for markets with low/medium technology, could be the 
focus of some programs.
The greatest challenge for a company focused exclusively 
on developing non-transgenic cultivars is the dispersion of 
this market. It increases the costs of marketing which is even 
more serious in relation to products with lower unit value, 
which is the case of non-transgenic cultivars (see Figure 
1). This condition limits the performance of the company 
to restricted regions, but with a planted area density with 
conventional seeds, enough to generate a regional demand 
that justifies the existence of the company. In the United 
States there are companies that survive in these condi-
tions, complementing their activities with the production 
and packaging of seeds for other companies that present a 
wider playing field, which do not want to engage in this 
segment (this activity, which is a form of outsourcing the 
physical part of seed production, is also present in Argen-
tina). Another situation that has occurred in the market and 
that may be related to farmer preference for non-transgenic 
cultivars is related to the emergence of non-target pests for 
transgenic events available in the market today, what would 
lead the farmer to have to re-do one to three, or even more 
insecticide applications.
As already mentioned, the main maize pest in the country 
has been the fall armyworm (Spodoptera frugiperda), and 
maize with Bt recent events has focused on controlling it. 
However, with the large planting areas with events that 
control this pest, insecticide application was reduced (which 
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is environmentally desirable), but the apparent sense of 
security in relation to insects control caused the farmer to 
stop making monitoring of pests in agriculture. This opened 
the way for pests from other cultures, or those previously 
considered not important in maize, to begin causing con-
siderable damage. The damages caused by sucking insects, 
such as green belly stink bug (Dichelops spp.), which once 
was exclusive of soybean, or the damage caused by aphids 
(Rhopalosiphum maidis) are some examples.
This change in the pattern of pests in transgenic crops can 
lead to a new situation. The farmer would have to return to 
using two to three insecticide applications to control second-
ary pests, which, in regions with lower attack of armyworms, 
no longer would justify using Bt seeds (since it would be 
necessary to apply insecticide to control non-target pests). 
In this case, regions and production systems that count with 
the infrastructure and personnel to make these applica-
tions (as occurs in various producers in the State of Mato 
Grosso, for example), could prove to be more economical 
to use conventional seed (with high yielding genetics) due 
to lower cost of this input. In this region, small differences 
in cost per hectare imply a large amount of revenue due to 
the scale on which they operate the properties. This would 
be a new opportunity for conventional breeding programs 
that would attend to this segment.
Another opportunity for breeding programs that have 
difficulty in accessing the market in the current scenario 
would be concentrating on the production of genetic materials 
(inbred lines, synthetics, populations source etc.) that contain 
some type of added technology (innovation assets) and that 
are of interest to other companies in the market. It would 
include elite lines (not germplasm material, but inbred lines 
with high combining ability that would be of interest to other 
programs) which present introgressed characteristics, such 
as: a) elite lines of high producibility of seed or pollen; b) 
lines that are sources of disease resistance, preferably with 
a well characterized genetics, both for plant and pathogen; 
c) sources of “conventional pest resistance genes”, which 
may increase the shelf life of events when combined with 
them; d) sources of efficient use of water and nutrients that 
are long-term studies, in which the private sector has no 
interest in investing using conventional breeding; e) sources 
of grain quality (e.g. resistance to mycotoxin) or lines that 
associate high combining ability with the grain type desired 
by the market (e.g. orange flint type etc).
Another segment to be exploited by conventional maize 
breeding programs would be specialized market niches 
such as sweet corn for canning and in natura consumption, 
popcorn, biofortified corn, corn with special types of starch 
or for traditional use (white corn for colonial mills in the 
South of Brazil, corn grits, corn for pudding and “pamonha”, 
etc). There are signs of breeding companies specializing in 
meeting some of these segments.
The new order in technological innovation in 
breeding programs
In any scenario related to access to transgenic technology, 
the ultimate goal of a breeding program should be to remain 
competitive in terms of genetics. This includes meeting the 
needs of the farmer in productivity, cycle (which in Brazil 
tends to be earlier in different crops, since the farmer evalu-
ates the profitability of the whole system and not of each crop 
individually), resistance to pests and diseases (in a world that 
will value more and more the so called “green agriculture”), 
yield stability, adaptation to target environments, tolerance 
to abiotic stresses (drought and high temperatures), nutrients 
use efficiency, etc. A number of innovations have occurred 
in maize breeding programs worldwide and Brazilian pro-
grams that want to remain competitive must accompany 
these advances even if on a smaller scale (the idea is not to 
mimic the large programs, but using innovative techniques 
in a scale compatible with the size of the company where the 
program is held). Some of these innovations are: a) use of 
double-haploid as tools to obtain inbred lines; b) use of marker 
assisted selection for various reasons such as allocation of lines 
to heterotic groups, to check the seed purity, or for genetic 
introgression of different characteristics in elite genotypes; c) 
use of new methods like Genome Wide Selection involving 
markers, phenotyping and new biometric models to maximize 
selection gains; d) use of bioinformatics tools to handle large 
datasets with phenotypic and genotypic information. The 
increased use of markers/genotyping in breeding programs 
can be done either with in-house structures or by contracting 
another company’s service, especially from other countries. 
This second option seems to be the faster and less expensive 
to one who wants to access this technology.
An indirect consequence of reducing the number of 
conventional (non GMO) cultivars in the Brazilian market 
is that historically they have been an important source of 
germplasm for some breeding programs in the country 
(which is permitted by Brazilian law, but not under U.S. 
law, for example). This should no longer happen with the 
increase in the participation of the transgenic cultivars in 
the market. The impact that this restriction will have in the 
rate of genetic gains in the maize breeding programs in the 
country is still unknown.
CONCLUSIONS
Although it has recently been introduced in Brazil, the 
transgenic cultivars have caused profound changes in the 
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seed market sector. Aspects related to the restriction of ac-
cess to these technologies have been discussed in different 
forums. It is still unclear how the assignments of use of 
traits will occur in the future. The outlook is not optimistic, 
and even if this happens, the conditions related to quality 
control (stewardship) will be more restrictive than those 
currently in use by smaller companies.
It is still unclear how to develop the utilization of events 
in which the intellectual protection has expired. This subject 
has been discussed in other countries (like the USA) but there 
is still a number of issues that need to be worked out before 
this could happen. Anyway, these public domain traits will 
always be an old technology, which in the maize seed market 
is usually a reason for lower product prices. Considering 
that the seed pricing of a particular cultivar involves aspects 
such as yield potential (incorporating pest resistance, cycle, 
response to fertilizer doses etc.), marketing actions (such 
as market presence, ease of acquisition, etc.) and post-sales 
(technical assistance, credit, acquisition of production, etc.) 
the technical and economic feasibility of using events in the 
public domain will take some time to be solved.
It seems certain that the existence of a maize breeding 
program that does not consider any option of introducing 
transgenic events has little chance of success. Actions to 
create a market for non-transgenic grains has had little effect 
on prices gotten by farmers for this type of product, and 
it requires a well developed logistic system in the area of 
segregation and greater control of the process as a whole.
An option for maize breeding programs is the devel-
opment of parental inbred lines that incorporate certain 
desirable characteristics to be used for hybrid production 
by other companies, instead of developing hybrids that 
need to be introduced in the market. Such innovations 
could have market value and ensure the survival of these 
breeding programs.
It must be understood that transgenic technology meant a 
structural break in the technological process but, at this point, 
with little impact on the productive potential of plants (the 
gains are mainly due to issues related to plant protection or 
convenience of use and do not directly increment the produc-
tive potential of these cultivars). Thus, the development of 
a superior genetics oriented towards the increase of factors 
affecting crop productivity will always be a constant quest. 
The problem is how these actions will be incorporated in an 
environment generated by this new technological paradigm. 
It will take place mainly in the legal environment (need 
for clarification of the rules relating to the release of the 
events covered by some sort of intellectual protection) or 
in the negotiation between companies. This development, 
as it occurs with the scientific advancement, is gradual and 
responds to market conditions of the technologies involved. 
However, a technical development of breeding programs is 
vital to its survival and adaptation to the new conditions of 
the seed market. Programs that fail to innovate will be left 
behind in terms of genetics. And there is no point having 
access to traits if there is no superior genetics.
Transgenics for insect control or for herbicide toler-
ance are important tools that should be used as part of an 
“Integrated Management System” (IMS) and not as a single 
strategy. This would be one area where private and public 
sector could set up partnerships to promote the highest level 
of technology benefits for farmers use and environmental 
preservation.
Finally, it should be recognized that commercial agricul-
ture in Brazil in recent decades has opted by technological 
adoption, and trangenesis is an important component in this 
segment. Finding a balance between the remuneration of 
private investment in innovation and an appropriate structure 
of the seed industry market is a complex task to be defined 
by Brazilian society.
Implicações da introdução de milho transgênico nos programas brasileiros de 
melhoramento
Resumo – A tecnologia de transgênicos em milho no Brasil foi liberada em 2008/2009 e em 2012 ocupou 73% da área de milho. Esta 
alta taxa de adoção confirma estudos que indicam que a opção por uso de tecnologia tem sido o principal fator do desenvolvimento 
da agricultura nacional. O mercado de sementes de milho no mundo em geral é concentrado, mas a transgenia ampliou esta concen-
tração. De um lado, há a ideia que as empresas podem se beneficiar dos ganhos de escala e complementaridades para maximizar sua 
eficiência de Pesquisa e Desenvolvimento. De outro, esta concentração pode permitir o exercício do chamado “poder de mercado” 
pelas empresas dominantes. O objetivo deste artigo foi analisar os impactos da adoção desta tecnologia no arranjo dos programas 
de melhoramento e no setor brasileiro de produção de sementes. Uma análise crítica da situação dos programas de melhoramento 
que não detêm esta tecnologia é feita.
Palavras-chave: Melhoramento de milho, concentração do mercado de sementes, transgenia.
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